Format

Send to:

Choose Destination
See comment in PubMed Commons below
J Am Acad Dermatol. 2003 Nov;49(5):873-8.

Low-dose methotrexate to treat mycosis fungoides: a retrospective study in 69 patients.

Author information

  • 1Department of Dermatology, Cancer Center, University of California-San Francisco, USA. hszackheim@orca.ucsf.edu

Abstract

BACKGROUND:

Although low-dose methotrexate has been used to treat mycosis fungoides for many years, documentation is very limited.

OBJECTIVE:

Our purpose was to review our experience with methotrexate in the treatment of 69 patients with patch/plaque and tumor stage mycosis fungoides observed for up to 201 months.

METHODS:

This was a retrospective study. Data are presented in terms of response rates and time to treatment failure.

RESULTS:

The greatest number of patients (60) had patch/plaque stage T2 disease (>/=10% skin involved). Of these, 7 (12%) achieved complete remission and 13 (22%) achieved partial remission for a total response rate of 20 of 60 (33%). The median time to treatment failure was 15 months. Only 1 of 7 patients with tumor stage disease responded. Side effects caused treatment failure in 6 (9%) of the total cohort of 69 patients.

CONCLUSION:

Low-dose methotrexate may be of value in the treatment of a subset of patients with patch/plaque mycosis fungoides resistant to other therapies.

PMID:
14576667
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk